2025 - Passed
Nebraska L.R.219
  • Directs the Nebraska Health and Human Services Committee of the Legislature to create a study to examine non-opioid treatment options in Medicaid.
Pain Study
Read Bill
2025 - Introduced
Nevada S.B. 377
  • Requires health insurers and Medicaid cover at least one alternative to an opioid and prohibits insurers from requiring prior authorization or other restrictive requirements for an alternative to an opioid compared to requirements established for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
New Hampshire H.B.241
  • Requires health insurance plans to cover a broad range of non-opioid pain management services, treat non-opioid therapies no less favorable than opioids, and provide educational materials to policyholders and coordinated care.
State Regulated Commercial Parity
Read Bill
2024 - Introduced
New Jersey A4682
  • Prohibits health insurers, Medicaid and School Employees’ Health Benefits from denying coverage of non-opioid prescription drugs in favor of opioid prescription drugs. Further, formularies are prohibited from disincentivizing the use of non-opioids with respect to coverage or cost-sharing.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2026 - Passed
New Jersey A5595
  • Allows individuals to create voluntary non-opioid directives, specifying that opioids should not be prescribed or administered, which must be recorded in their medical record and can be revoked at any time.
  • Grants health care providers legal immunity when following the directive.
Opioid Directive
Read Bill
2025 - Passed
North Dakota S.B. 2113
  • Creates a study that will examine non-opioid pharmacological treatment options and assess the use of existing opioid settlement funds. Additionally, the study will explore strategies to utilize these funds for the development and implementation of an education and awareness initiative regarding non-opioid pain management options.
Pain Study
Read Bill
2025 - Introduced
Oklahoma H.B.1416
  • Ensures that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to coverage relative to an opioid for the treatment or management of pain on the state preferred drug list.
State Employee Health Plan Parity
Read Bill
2024 - Passed
Oklahoma S.B.1344
  • Requires that the state Medicaid preferred drug list and utilization management not disadvantage a non-opioid pain medication relative to an opioid pain medication.
  • Requires the state government to seek grant opportunities relating to education and services regarding non-opioid medications.
  • Provides that the state may assist in using opioid settlement funds to support education regarding non-opioid alternatives.
Medicaid ParityEducation
Read Bill
2025 - Passed
Oregon H.B. 3211
  • Requires the Oregon Health Authority to develop a non-opioid directive form.
Read Bill
2025 - Introduced
Oregon S.B.598
  • Requires health insurers and Medicaid establish parity for opioids and non-opioid treatments.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2026 - Introduced
Pennsylvania H.B. 2060
  • Requires Medicaid and commercial insurers to provide pain parity by ensuring FDA-approved non opioid drugs are not disadvantaged in coverage, cost sharing, or utilization controls compared with opioids, applying upon FDA approval.
Medicaid ParityState Employee Health Plan Parity
Read House Bill
2025 - Introduced
South Carolina S.B. 161/H.B. 4165
  • Prohibits preferencing coverage of an opioid prescription treatment over a non-opioid treatment and requires the South Carolina Department of Public Health to create educational materials and guidelines for practitioners about non-opioid alternative treatment options.
Medicaid ParityEducation
Read Senate BillRead House Bill